早产子痫前期高风险孕妇的心功能:阿司匹林与安慰剂对比观察研究
该研究比较了早产子痫前期低风险与高风险孕妇的血流动力学,以及高风险孕妇随机接受阿司匹林或安慰剂后的差异。低风险组心脏输出量增加而平均动脉压和外周血管阻力下降;高风险组心脏输出量下降而平均动脉压和外周血管阻力升高。阿司匹林预防性使用未改变这些血流动力学特征。
要点
- 早产子痫前期高风险孕妇存在病理性心脏适应,表现为心脏输出量下降。
- 预防性使用阿司匹林150mg未改变高风险孕妇的血流动力学特征。
- 低风险孕妇呈现心脏输出量增加、平均动脉压和外周血管阻力下降的正常模式。
核心结论
- 被筛查为早产子痫前期高风险的孕妇存在病理性心脏适应,预防性使用阿司匹林可能不改变这种血流动力学特征。
研究设计与样本
- 前瞻性纵向观察研究,纳入参与ASPRE试验的孕妇,分为低风险组(n=1362)、高风险阿司匹林组(n=208)和高风险安慰剂组(n=220)。
- 在妊娠11-14、19-24、30-34和35-37周进行四次访视,使用经过妊娠验证的血压设备和生物电抗监测仪评估子痫前期和母体血流动力学。
主要发现
- 低风险组显示心脏输出量增加、平均动脉压和外周血管阻力下降,随妊娠呈二次变化。
- 高风险组在妊娠期间心脏输出量下降,平均动脉压和外周血管阻力升高。
- 阿司匹林给药似乎不影响母体血流动力学。
临床怎么用
- 对于早产子痫前期高风险孕妇,应关注其病理性心脏适应,但阿司匹林预防性使用可能不改善血流动力学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare maternal haemodynamics in women at low and high risk for preterm pre-eclampsia (PE), and between those at high risk who are randomised to aspirin or placebo. DESIGN: Prospective, longitudinal observational study. SETTING: Maternity units in six UK hospitals. POPULATION: Women participating in the Aspirin for Prevention of Preterm Pre-eclampsia (ASPRE) trial. The population comprised three groups of women: low risk for preterm PE (n = 1362), high risk for preterm PE treated with aspirin (n = 208) and high risk for preterm PE on placebo (n = 220). METHODS: Women had four visits during pregnancy: 11-14, 19-24, 30-34, and 35-37 weeks' gestation. Blood pressure was measured with a device validated for pregnancy, and PE and maternal haemodynamics were assessed with a bioreactance monitor at each visit. A multilevel linear mixed-effects analysis was performed to examine longitudinal changes of maternal haemodynamic variables, controlling for demographic characteristics, past medical history and medication use. MAIN OUTCOME MEASURES: Longitudinal changes of cardiac output (CO), mean arterial pressure (MAP), and peripheral vascular resistance (PVR). RESULTS: The low-risk group demonstrated the expected changes with an increase in CO and reduction in MAP and PVR, with a quadratic change across gestation. In contrast, the high-risk groups had a declining CO, and higher MAP and PVR during pregnancy. The administration of aspirin did not appear to affect maternal haemodynamics. CONCLUSIONS: Women screened as high risk for preterm PE have a pathological cardiac adaptation to pregnancy and the prophylactic use of aspirin (150 mg oral daily from the first trimester) in this group may not alter this haemodynamic profile. TWEETABLE ABSTRACT: In women at high risk of pre-eclampsia, prophylactic use of aspirin may not alter the impaired maternal cardiac adaptation.
引用
- Ling HZ, Jara PG, Bisquera A, et al. Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study. BJOG. 2020. PMID: 32133780. doi:10.1111/1471-0528.16193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。